This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Health Care ETFs Outperforming: Will the Rally Last?
by Sanghamitra Saha
Health care ETFs are defensive ones, which helped those to shine amid market doldrums.
Cola Earnings Add Fizz to Consumer Staples ETFs
by Sanghamitra Saha
Inside the cola earnings and their impact on ETFs.
Should You Invest in the FID-STAPLES (FSTA)?
by Zacks Equity Research
Sector ETF report for FSTA
PepsiCo Q2 Earnings Aid Staples ETFs, Are Gains Transitory?
by Sanghamitra Saha
PepsiCo's earnings may push up staples ETFs lately, but these could be a short-term boost.
Consumer Staples ETF (XLP) Hits New 52-Week High
by Sweta Killa
This consumer staples ETF hits a new 52-week high. Are more gains in store for this ETF?
Consumer Staples ETFs Riding High on Trade War Fears
by Sweta Killa
Global trade war fears have started to make investors' jittery, leading to a rotation of sectors to consumer staples.
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Sweta Killa
Sector ETF report for FSTA
Wal-Mart's Solid Q1 Results Put These ETFs in Focus
by Sweta Killa
Wal-Mart managed to deliver positive earnings surprise after missing estimates in the fourth quarter of fiscal 2018.
Will Q1 Earnings Bring More Pain for Wal-Mart ETFs?
by Sweta Killa
ETFs having the highest allocation to the world's largest brick and mortar retailer will be in focus going into its earnings announcement.
Walmart Acquires 77% in Flipkart: ETFs in Focus
by Zacks Equity Research
In one of the largest e-commerce deals, Walmart has decided to acquire a 77% stake in India-based Flipkart.
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Sweta Killa
Sector ETF report for FSTA
Don't Sell in May and Go Away: Follow These ETF Strategies
by Sweta Killa
Investors could follow some ideas that could lead to a winning portfolio during this soft six-month period.
ETFs in Focus Post Phillip Morris' Downbeat Earnings
by Zacks Equity Research
Philip Morris beats earnings but misses revenue estimates; cigarette sales take a hit.
Why P&G Weighs on Staples ETFs Despite Beating Estimates
by Sanghamitra Saha
Better-than-expected results and a big-ticket acquisition could not save Procter & Gamble stock. Time to stave off from staples ETFs?
Winning ETF Areas of March
by Sanghamitra Saha
Inside the ETFs that raked in sizable assets in March.
Top and Flop Sectors of Q1 and Their Wining & Losing Stocks
by Sanghamitra Saha
Inside the top and flop sectors of Q1 and their related winning and losing Stocks.
Wal-Mart's Dismal Q4 Results Drag Consumer Staples ETFs Down
by Sweta Killa
Wal-Mart's nine-quarter long positive earnings surprise streak came to an end as it recorded slower growth in online sale.
ETFs in Focus After Phillip Morris's Downbeat Q4 Results
by Zacks Equity Research
Philip Morris misses earnings and revenue estimates.
January ETF Asset Report: S&P 500 Wins, High-Yield Loses
by Sanghamitra Saha
Thanks to upbeat earnings, the S&P 500 based ETFs hauled in maximum assets. Bonds fell flat.
Staples ETFs: What Investors Need to Know
by Sanghamitra Saha
Consumer Staples stocks and ETFs are tied into the positive of strong consumer sentiment and negative of rising rate prospects.
Rate Hike in the Cards? Discard These Sector ETFs
by Sanghamitra Saha
Stay away from these sector ETFs if rates rise further.
Wal-Mart ETFs to Buy on Blockbuster Q3 Results
by Sweta Killa
Given the solid domestic growth and guidance, Wal-Mart had its biggest rally in more than nine years.
Consumer Staples ETFs Head to Head: XLP vs. VDC
by Zacks Equity Research
Head to head comparison of two Consumer Staples ETFs, XLP and VDC.
October ETF Asset Report: U.S. Equities Prevail
by Sanghamitra Saha
Inside the ETF asset-flows in the month of October.
ETFs in Focus After Phillip Morris's Downbeat Results
by Zacks Equity Research
Philip Morris's Q3 results fail to beat Zacks consensus estimates on both revenue and EPS fronts.